Delivery Order SPE2DB24D1107-SPE2DB25FZGQ2
- Not listed
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,761.94 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,372.92 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on June 18, 2025, with an ultimate completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a firm fixed price structure and completion date of September 15, 2025. This is an unset-aside, competitively awarded contract issued on September 12, 2025, with performance to be completed at the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $13,651.84 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,726.60 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for NovoLog 100 Unit/mL vials (10 mL) with a completion date of August 4, 2025. This firm fixed price delivery order, which represents a non-set-aside competitive award, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,803.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for NovoLog 100 Unit/mL vials (10 mL units). This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,040.41. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL) with a ceiling value of $1,619.42. This firm fixed-price delivery order is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $5,186.40 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, supporting the agency's medical supply...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGQ2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,889.80 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL) with a completion deadline of September 15, 2025. This competitive, firm fixed-price delivery order was issued without set-aside designation on September 12, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply procurement across the Department of Defense. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal military and veteran healthcare procurement. As a prime contractor under the DLA Troop Support Medical umbrella, the company supplies a comprehensive portfolio of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. The NovoLog insulin delivery under this order supports the Defense Health Agency and broader military medical supply chain requirements for diabetes management medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/12/25 |